AbbVie
Tracked across 8 events · 61 articles · First seen Apr 17, 2025 · Last active Jun 30, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
International
Impact: AbbVie is being investigated by the United States — House Select Committee on the Chinese Communist Party regarding its clinical trials in China, especially in China — Xinjiang and at military hospitals. This investigation highlights ethical and security risks for AbbVie and could lead to negative market sentiment and regulatory challenges.
Apr 20, 2026 · 8 articles
Regulatory
Impact: AbbVie is expected to announce a deal with the Donald Trump administration after the holidays.
Dec 19, 2025 · 7 articles
Tech
Impact: AbbVie Inc. is a funding partner for the project, supporting the research into Alzheimer s disease biomarkers.
Feb 19, 2026 · 6 articles
Coeptis Therapeutics Holdings
acquirer
↔
AbbVie
AbbVie agreed to acquire Cerevel Therapeutics Holdings for $45 per share in a tr
Bain Capital
unrelated
↔
AbbVie
AbbVie does not have a direct structural or commercial relationship with Bain Ca
Coeptis Therapeutics Holdings
target
↔
AbbVie
Cerevel Therapeutics Holdings agreed to be acquired by pharmaceutical giant AbbV
Bain Capital
unrelated
↔
AbbVie
Bain Capital does not have a direct structural or commercial relationship with A
ERGEN INTELLIGENCE
Track AbbVie live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard